Paxlovid, Pfizer’s oral COVID-19 pill, set to be approved in Canada
Global News -

Pfizer began a rolling submission with Health Canada in December for Paxlovid, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply.

Read this story at

Loading...

Related Articles